Web Stats Provided By Google Analytics

Monday, January 22, 2018

CymaBay Therapeutics Inc (CBAY) Expected to Post Quarterly Sales of $6.75 Million

... Management LLC bought a new position in shares of CymaBay Therapeutics during the 3rd quarter valued at $404,000. Ardsley Advisory Partners lifted its holdings in shares of CymaBay Therapeutics by 66.2% during the 2nd quarter. Ardsley Advisory ...
https://www.chaffeybreeze.com/2018/01/22/cymabay-therapeutics-inc-cbay-expected-to-post-quarterly-sales-of-6-75-million.html

No comments:

Post a Comment

Popular Ardsley Roundup Posts